Clinical Trials Browser

Phase 2 × Withdrawn × Thyroid Neoplasms × Clear all

NCT04731740 2024-03-25

Pembrolizumab and Lenvatinib/Chemotherapy for Poorly Differentiated/Anaplastic Thyroid Cancer

Phase 2 Withdrawn

Thyroid Neoplasms

NCT01747512 2017-11-14

An Imaging Study in Patients With Thyroid Cancer or Head and Neck Cancer With Pertechnetate Made in a Cyclotron (C-PERT)

Phase 2 Withdrawn

Head and Neck Neoplasms, Thyroid Neoplasms